Starowicz K et al. |
Biochemistry and pharmacology of endovanilloids. |
2007 |
Pharmacol. Ther. |
pmid:17349697
|
Burstein SH |
The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential. |
1999 |
Pharmacol. Ther. |
pmid:10341359
|
Izzo AA and Sharkey KA |
Cannabinoids and the gut: new developments and emerging concepts. |
2010 |
Pharmacol. Ther. |
pmid:20117132
|
Porter AC and Felder CC |
The endocannabinoid nervous system: unique opportunities for therapeutic intervention. |
2001 |
Pharmacol. Ther. |
pmid:11448725
|
Woodward DF et al. |
The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. |
2008 |
Pharmacol. Ther. |
pmid:18700152
|
McFarland MJ and Barker EL |
Anandamide transport. |
2004 |
Pharmacol. Ther. |
pmid:15518883
|
Randall MD et al. |
Cardiovascular effects of cannabinoids. |
2002 |
Pharmacol. Ther. |
pmid:12182966
|
Snider NT et al. |
Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. |
2010 |
Pharmacol. Rev. |
pmid:20133390
|
Blankman JL and Cravatt BF |
Chemical probes of endocannabinoid metabolism. |
2013 |
Pharmacol. Rev. |
pmid:23512546
|
Mulè F et al. |
Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. |
2007 |
Pharmacol. Res. |
pmid:17574859
|
Khasabova IA et al. |
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy. |
2014 |
Pharmacol. Res. |
pmid:25304184
|
Mulè F et al. |
Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. |
2007 |
Pharmacol. Res. |
pmid:17656103
|
Navarria A et al. |
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. |
2014 |
Pharmacol. Res. |
pmid:24861565
|
Kerr DM et al. |
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid. |
2016 |
Pharmacol. Res. |
pmid:27592249
|
Yousif MH and Oriowo MA |
Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments. |
1999 |
Pharmacol. Res. |
pmid:10527656
|
Spradley JM et al. |
Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. |
2010 |
Pharmacol. Res. |
pmid:20416378
|
Guindon J et al. |
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. |
2013 |
Pharmacol. Res. |
pmid:23127915
|
De Petrocellis L et al. |
N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity. |
2011 |
Pharmacol. Res. |
pmid:21215315
|
Stefano GB et al. |
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. |
2000 |
Pharmacol. Res. |
pmid:10987990
|
Malek N et al. |
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. |
2016 |
Pharmacol. Res. |
pmid:27326920
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
Nicolussi S et al. |
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice. |
2014 |
Pharmacol. Res. |
pmid:24412246
|
Maione S et al. |
Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics. |
2013 |
Pharmacol. Res. |
pmid:23911581
|
Khasabova IA et al. |
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. |
2011 |
Pharmacol. Res. |
pmid:21440630
|
Baranowska-Kuczko M et al. |
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery. |
2012 |
Pharmacol. Res. |
pmid:22627170
|
Fowler CJ et al. |
The endocannabinoid signaling system: pharmacological and therapeutic aspects. |
2005 |
Pharmacol. Biochem. Behav. |
pmid:15935456
|
Smith FL et al. |
Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9610941
|
Wiley JL |
Cannabis: discrimination of "internal bliss"? |
1999 |
Pharmacol. Biochem. Behav. |
pmid:10515300
|
Romero J et al. |
Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. |
1995 |
Pharmacol. Biochem. Behav. |
pmid:7675852
|
Wiley JL and Burston JJ |
Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats. |
2010 |
Pharmacol. Biochem. Behav. |
pmid:19941884
|
Herrera-SolÃs A et al. |
Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats. |
2010 |
Pharmacol. Biochem. Behav. |
pmid:20056119
|
Rawls SM et al. |
Role of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats. |
2006 |
Pharmacol. Biochem. Behav. |
pmid:16647109
|
Crawley JN et al. |
Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. |
1993 |
Pharmacol. Biochem. Behav. |
pmid:7906042
|
Wiley JL et al. |
Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9408225
|
Wenger T et al. |
The effects of prenatally administered endogenous cannabinoid on rat offspring. |
1997 |
Pharmacol. Biochem. Behav. |
pmid:9300616
|
Reyes-Cabello C et al. |
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration. |
2012 |
Pharmacol. Biochem. Behav. |
pmid:22133635
|
Tuboly G et al. |
The antinociceptive interaction of anandamide and adenosine at the spinal level. |
2009 |
Pharmacol. Biochem. Behav. |
pmid:18760296
|
Sulcova E et al. |
Biphasic effects of anandamide. |
1998 |
Pharmacol. Biochem. Behav. |
pmid:9476980
|
Sadhasivam S et al. |
Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects. |
2015 |
Pharmacogenomics J. |
pmid:25558980
|
Laine K et al. |
Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits. |
2001 |
Pharm. Res. |
pmid:11451037
|
Pate DW et al. |
Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits. |
1997 |
Pharm. Res. |
pmid:9453062
|
Krishtal O et al. |
The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids. |
2006 |
Pflugers Arch. |
pmid:16741755
|
Kenessey I et al. |
Revisiting CB1 receptor as drug target in human melanoma. |
2012 |
Pathol. Oncol. Res. |
pmid:22447182
|
Farquhar-Smith WP et al. |
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. |
2002 |
Pain |
pmid:12031775
|
Horvath G et al. |
The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. |
2008 |
Pain |
pmid:17533116
|
Lichtman AH et al. |
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. |
2004 |
Pain |
pmid:15157693
|
Guindon J et al. |
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. |
2006 |
Pain |
pmid:16480822
|
Jaggar SI et al. |
The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. |
1998 |
Pain |
pmid:9696473
|
Butler RK et al. |
Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. |
2008 |
Pain |
pmid:19004548
|
Richardson JD et al. |
Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. |
1998 |
Pain |
pmid:9539680
|
Jia J et al. |
Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase. |
2014 |
Oxid Med Cell Longev |
pmid:25136404
|
Palkovits M |
[The brain and the pain: neurotransmitters and neuronal pathways of pain perception and response]. |
2000 |
Orv Hetil |
pmid:11184247
|
Scholl A et al. |
Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2. |
2016 |
Oncotarget |
pmid:27556861
|
Ravi J et al. |
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway. |
2014 |
Oncotarget |
pmid:24811863
|
Orellana-Serradell O et al. |
Proapoptotic effect of endocannabinoids in prostate cancer cells. |
2015 |
Oncol. Rep. |
pmid:25606819
|
Bernabò N et al. |
Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol. |
2013 |
OMICS |
pmid:24117401
|
Tong S et al. |
Diagnostic accuracy of maternal serum macrophage inhibitory cytokine-1 and pregnancy-associated plasma protein-A at 6-10 weeks of gestation to predict miscarriage. |
2012 |
Obstet Gynecol |
pmid:22525911
|
Haas MJ et al. |
Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids. |
2012 |
Obesity (Silver Spring) |
pmid:22016100
|
Gonthier MP et al. |
Identification of endocannabinoids and related compounds in human fat cells. |
2007 |
Obesity (Silver Spring) |
pmid:17426318
|
Engeli S et al. |
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects. |
2014 |
Obesity (Silver Spring) |
pmid:24616451
|
Starowicz KM et al. |
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. |
2008 |
Obesity (Silver Spring) |
pmid:18239598
|
Karaliota S et al. |
Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation. |
2009 |
Obesity (Silver Spring) |
pmid:19543211
|
Zelber-Sagi S et al. |
Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease. |
2017 |
Obesity (Silver Spring) |
pmid:27863097
|
Abdulnour J et al. |
Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. |
2014 |
Obesity (Silver Spring) |
pmid:23616305
|
Engeli S et al. |
Peripheral endocannabinoid system activity in patients treated with sibutramine. |
2008 |
Obesity (Silver Spring) |
pmid:18356837
|
Alvheim AR et al. |
Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. |
2012 |
Obesity (Silver Spring) |
pmid:22334255
|
Romero TR et al. |
The neuronal NO synthase participation in the peripheral antinociception mechanism induced by several analgesic drugs. |
2011 |
Nitric Oxide |
pmid:21875681
|
Kamei J et al. |
[Sensitization of cough sensitivity through activation of C-and/or Adelta fibers]. |
2008 |
Nippon Yakurigaku Zasshi |
pmid:18552444
|
Yamaguchi Y et al. |
[Surgical stress]. |
2005 |
Nihon Geka Gakkai Zasshi |
pmid:16045189
|
Kudo R and Hatake K |
[Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation]. |
2006 |
Nihon Arukoru Yakubutsu Igakkai Zasshi |
pmid:17313058
|
Hayase T et al. |
Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity. |
2001 |
Nihon Arukoru Yakubutsu Igakkai Zasshi |
pmid:11828716
|
Kudo R and Hatake K |
[Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation (the second report)]. |
2008 |
Nihon Arukoru Yakubutsu Igakkai Zasshi |
pmid:18646646
|
Deutsch DG and Makriyannis A |
Inhibitors of anandamide breakdown. |
1997 |
NIDA Res. Monogr. |
pmid:9260184
|
Liu J and Pope C |
The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats. |
2015 |
Neurotoxicology |
pmid:25447325
|
Harvey BS et al. |
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro. |
2012 |
Neurotoxicology |
pmid:22233683
|
Carr RL et al. |
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development. |
2017 |
Neurotoxicology |
pmid:26642910
|
Carr RL et al. |
Low level chlorpyrifos exposure increases anandamide accumulation in juvenile rat brain in the absence of brain cholinesterase inhibition. |
2014 |
Neurotoxicology |
pmid:24373905
|
Gasperi V et al. |
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. |
2005 |
Neurotoxicology |
pmid:16154199
|
Smaga I et al. |
Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures. |
2014 |
Neurotox Res |
pmid:24652522
|
Smaga I et al. |
Changes in the Brain Endocannabinoid System in Rat Models of Depression. |
2017 |
Neurotox Res |
pmid:28247204
|
Doroshenko P and Renaud LP |
Acid-sensitive TASK-like K+ conductances contribute to resting membrane potential and to orexin-induced membrane depolarization in rat thalamic paraventricular nucleus neurons. |
2009 |
Neuroscience |
pmid:19135504
|
Mahmud A et al. |
Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. |
2009 |
Neuroscience |
pmid:19463903
|
Dowie MJ et al. |
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. |
2009 |
Neuroscience |
pmid:19524019
|
Straiker A and Mackie K |
Cannabinoid signaling in inhibitory autaptic hippocampal neurons. |
2009 |
Neuroscience |
pmid:19501632
|
De Petrocellis L et al. |
Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. |
1999 |
Neuroscience |
pmid:10392859
|
Musella A et al. |
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. |
2010 |
Neuroscience |
pmid:20219639
|
Tree K et al. |
Anandamide centrally depresses the respiratory rhythm generator of neonatal mice. |
2010 |
Neuroscience |
pmid:20800658
|
Szoke E et al. |
Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion. |
2002 |
Neuroscience |
pmid:12435419
|
Veeraraghavan P et al. |
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro. |
2016 |
Neuroscience |
pmid:27450568
|
Palkovits M et al. |
Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. |
2008 |
Neuroscience |
pmid:18343585
|
Yang W et al. |
Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells. |
2016 |
Neuroscience |
pmid:26621126
|
Schmidt W et al. |
Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia. |
2012 |
Neuroscience |
pmid:23069763
|
Sticht MA et al. |
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats. |
2015 |
Neuroscience |
pmid:25499318
|
Palmer JA et al. |
Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. |
2008 |
Neuroscience |
pmid:18541380
|
Murillo-RodrÃguez E et al. |
The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. |
2008 |
Neuroscience |
pmid:18822353
|
Singh Tahim A et al. |
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons. |
2005 |
Neuroscience |
pmid:16198486
|
Muthian S et al. |
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. |
2004 |
Neuroscience |
pmid:15541895
|
de Oliveira Alvares L et al. |
Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction. |
2008 |
Neuroscience |
pmid:18554811
|
Milton NG |
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. |
2002 |
Neurosci. Lett. |
pmid:12384227
|
Abalo R et al. |
Evaluation of the effect of age on cannabinoid receptor functionality and expression in guinea-pig ileum longitudinal muscle-myenteric plexus preparations. |
2005 Jul 22-29 |
Neurosci. Lett. |
pmid:15936532
|